Drugs@FDA document
SKYRIZI Letter · BLA 761105 SUPPL-39
Drugs@FDA document · ABBVIE INC · Sep 4, 2025
Key facts
| Drug name | SKYRIZI |
|---|---|
| Document type | Letter |
| Application | BLA761105 |
| Submission | SUPPL-39 |
| Company | ABBVIE INC |
| Document date | Sep 4, 2025 |
At a glance
- Efficacy-Manufacturing Change With Clinical Data Document categories
- 10–99 Documents for this application
- 1–9 USP chapters cited in this application's documents
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About Drugs@FDA documents
Drugs@FDA posts the letters, labels, reviews and other documents behind each drug application and supplement. Orca1 indexes every document's full text and flags complete response letters.
Source: U.S. Food and Drug Administration (FDA), Drugs@FDA application documents · Source date: